Clinical Trial Update: Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. [Phase 3]

View source ↗

Summary

A Phase III randomized trial is evaluating 5-FU with CoFactor plus Avastin versus 5-FU with leucovorin plus Avastin as first-line therapy for colorectal cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Avastin (bevacizumab)
• CoFactor (5,10-methylenetetrahydrofolate)
• Leucovorin (folinic acid)

Snippet

Sponsor: Mast Therapeutics, Inc. | Conditions: Metastatic Colorectal Cancer, Colon Cancer | Phase 3 | Status: UNKNOWN